Cloning, expression and characterization of a peptibody to deplete myeloid derived suppressor cells in a murine mammary carcinoma model-Reference-Cited by-同舟云学术

Cloning, expression and characterization of a peptibody to deplete myeloid derived suppressor cells in a murine mammary carcinoma model

Published:2022-12 Issue: Volume:200 Page:106153
ISSN:1046-5928
Container-title:Protein Expression and Purification
language:en
Short-container-title:Protein Expression and Purification

Author:

Ramezani-Ali Akbari Khadijeh,Khaki-Bakhtiarvand Vahid,Mahmoudian Jafar,Asgarian-Omran Hossein,Shokri Fazel,Hojjat-Farsangi Mohammad,Jeddi-Tehrani Mahmood,Shabani Mahdi

Funder

Mazandaran University of Medical Sciences

Avicenna Research Institute

Shahid Beheshti University of Medical Sciences

Shahid Beheshti University of Medical Sciences School of Medicine

Iran National Science Foundation

Publisher

Elsevier BV

Subject

Biotechnology

Reference42 articles.

1. Myeloid-derived suppressor cells as regulators of the immune system;Gabrilovich;Nat. Rev. Immunol.,2009

2. Tumors induce a subset of inflammatory monocytes with immunosuppressive activity on CD8+ T cells;Gallina;J. Clin. Invest.,2006

3. Myeloid suppressor cells in cancer: recruitment, phenotype, properties, and mechanisms of immune suppression;Serafini;Semin. Cancer Biol.,2006

4. Recommendations for myeloid derived suppressor cell nomenclature and characterization standards;Bronte;Nat. Commun.,2016

5. Increased production of immature myeloid cells in cancer patients: a mechanism of immunosuppression in cancer;Almand;J. Immunol.,2001

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Signaling controversy and future therapeutical perspectives of targeting sphingolipid network in cancer immune editing and resistance to tumor necrosis factor-α immunotherapy;Cell Communication and Signaling;2024-05-02

2. Evaluation of the anti-tumor effects of an anti-Human Epidermal growth factor receptor 2 (HER2) monoclonal antibody in combination with CD11b+/Gr-1+ myeloid cells depletion using a recombinant peptibody in 4 T1-HER2 tumor model;International Immunopharmacology;2023-08